Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7778]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Understanding failure in targeted breast cancer therapy
Dr Martin Jechlinger - EMBL Monterotondo, Rome, Italy
Understanding failure in targeted breast cancer therapy ( Dr Martin Jechlinger - EMBL Monterotondo, Rome, Italy )
21 Jul 2015
De-activating chromosomes to prevent cancer
Dr Philip Avner - Head of EMBL Monterotondo, Milan, Italy
De-activating chromosomes to prevent cancer ( Dr Philip Avner - Head of EMBL Monterotondo, Milan, Italy )
21 Jul 2015
New emerging treatments in multiple myeloma
Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Heinz Ludwig, Prof Philippe...
New emerging treatments in multiple myeloma ( Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Heinz Ludwig, Prof Philippe Moreau, Prof Mario Boccadoro )
7 Jul 2015
How can a systems biology approach aid precision cancer medicine?
Dr Andrea Califano, Columbia University Department of Systems Biology, New York...
How can a systems biology approach aid precision cancer medicine? ( Dr Andrea Califano, Columbia University Department of Systems Biology, New York, USA )
6 Jul 2015
Moving precision medicine for lung cancer into the adjuvant setting
Dr Don Gibbons - The University of Texas MD Anderson Cancer Center, Houston, USA
Moving precision medicine for lung cancer into the adjuvant setting ( Dr Don Gibbons - The University of Texas MD Anderson Cancer Center, Houston, USA )
6 Jul 2015
WIN Symposium 2015 highlights
Prof Richard Schilsky - Chief Medical Officer of the American Society of...
WIN Symposium 2015 highlights ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )
6 Jul 2015
Next generation of trials with targeted agents
Prof Richard Schilsky - Chief Medical Officer of the American Society of...
Next generation of trials with targeted agents ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )
6 Jul 2015
Ibrutinib combined with bendamustine plus rituximab in previously treated CLL...
Dr Paula Cramer - University of Cologne, Köln, Germany
Ibrutinib combined with bendamustine plus rituximab in previously treated CLL and SLL ( Dr Paula Cramer - University of Cologne, Köln, Germany )
30 Jun 2015
Chemoresistance and residual disease promoted by DNMT3A R882 in AML
Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
Chemoresistance and residual disease promoted by DNMT3A R882 in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Jun 2015
TAT 2016: Targeted anticancer therapies
Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA
TAT 2016: Targeted anticancer therapies ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )
19 Jun 2015
Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL
Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands
Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL ( Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands )
17 Jun 2015
EHA 2015 highlights
Peter Goodwin - ecancer reporter
EHA 2015 highlights ( Peter Goodwin - ecancer reporter )
17 Jun 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation